Please login to the form below

Not currently logged in
Email:
Password:

Sanofi appoints immunology and inflammation research global head

Dr Frank Nestle also becomes North America chief scientific officer

Sanofi Dr Frank NestleSanofi has appointed Dr Frank Nestle as both the global head of immunology and inflammation research therapeutic area and North America chief executive officer.

Based out of the French firm's Cambridge, Massachusetts office, Dr Nestle will be responsible for developing Sanofi's early stage immunology and inflammations portfolio and driving its scientific intelligence across multiple therapeutic areas in the US.

He joins Sanofi from King's College London, where he was the Mary Dunhill professor and chair of cutaneous medicine and immunotherapy.

Currently, Dr Nestle serves as lead biomarker for the co-diagnostics, imaging and devices cluster at the Biomedical Research Centre and is the outgoing president of the Federation of Clinical Immunology Societies.

He is a fellow of the Academy of Medical Sciences, a senior investigator emeritus at the National Institute for Health Research and has also served as a non-executive director at Guy's and St Thomas' Foundation Trust Hospital.

12th September 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics